Costa Neto, Abel; Santos, Flavia; Ribeiro, Ingrid; Oliveira, Valeria; Dezan, Marcia; Kashima, Simone; Covas, Dimas Tadeu 
; Krieger, Jose Eduardo ; Gualandro, Sandra Fátima Menosi ; Rocha, Vanderson Geraldo
Fonte: Transfusion. Unidades: FMRP, FM
Assuntos: AUTOIMUNIDADE, DOENÇAS AUTOIMUNES, GENÓTIPOS, PACIENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA NETO, Abel et al. FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients. Transfusion, v. 60, n. 7, p. 1573-1578, 2020Tradução . . Disponível em: https://doi.org/10.1111/trf.15832. Acesso em: 02 ago. 2024.APA
Costa Neto, A., Santos, F., Ribeiro, I., Oliveira, V., Dezan, M., Kashima, S., et al. (2020). FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients. Transfusion, 60( 7), 1573-1578. doi:10.1111/trf.15832NLM
Costa Neto A, Santos F, Ribeiro I, Oliveira V, Dezan M, Kashima S, Covas DT, Krieger JE, Gualandro SFM, Rocha VG. FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients [Internet]. Transfusion. 2020 ; 60( 7): 1573-1578.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1111/trf.15832Vancouver
Costa Neto A, Santos F, Ribeiro I, Oliveira V, Dezan M, Kashima S, Covas DT, Krieger JE, Gualandro SFM, Rocha VG. FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients [Internet]. Transfusion. 2020 ; 60( 7): 1573-1578.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1111/trf.15832
